Actavis, Mylan Settle IP Suit Over Generic Birth Control Drug
Actavis PLC has entered an agreement with generic drugmakers Mylan Laboratories Inc. and its partner Famy Care Ltd. to settle outstanding patent litigation over chewable tablets of the birth control drug...To view the full article, register now.
Already a subscriber? Click here to view full article